As the prognosis of patients with MM is improved with higher CD8+ T cells in the TILs,46 the numbers of human CD45+ cells, CD3+ T cells, CD4+ T cells, CD8+ T cells, and T regulatory cells per gram of tumor tissue in each treated group was analyzed via flow cytometry. The gene discussed is PTPRC; the disease is Miyoshi myopathy.